Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 7/31/2014 10:42:15 AM - Followers: 444 - Board type: Free - Posts Today: 24

Cellceutix Corporation (CTIX) 



Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


Management:   http://cellceutix.com/team/
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
Product Pipeline:  http://cellceutix.com/pipeline/

Recent News and Press Releases: 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure
Investor Relations:  info@cellceutix.com


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 06/23/2014 07:00:00 AM
CTIX News: Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort 06/16/2014 07:00:00 AM
CTIX News: Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol 06/02/2014 07:00:00 AM
CTIX News: Cellceutix Signs Material Transfer Agreements for Defensin Mimetic Compounds With Leading Universities 05/27/2014 07:00:00 AM
CTIX News: Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market 05/19/2014 07:00:00 AM
#63926  Sticky Note New Blog post from Ellaruth on seeking alpha. jok 07/25/14 02:31:30 AM
#62804  Sticky Note Research and development grants for the 3 months BooDog 07/02/14 07:15:59 AM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#51541  Sticky Note Very impressive and positive CTIX PR and presentation! TOB 01/15/14 02:41:11 PM
#39163  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and chart: KarinCA 08/25/13 03:20:25 PM
#64192   I just bought 1000 at $1.64??? How? Usually TheDane 07/31/14 10:42:15 AM
#64191   I believe that's correct. Continuing the aquarium CallMeCrazy 07/31/14 10:31:46 AM
#64190   I believe the P2B data will be unblinded CallMeCrazy 07/31/14 10:17:55 AM
#64189   And the aquarium (membrane) won't hold water again... GregChase 07/31/14 10:16:51 AM
#64188   Is this the timeline for "B"? GregChase 07/31/14 10:14:59 AM
#64187   THANKS FOR POSTING THAT!! cabel 07/31/14 10:13:48 AM
#64186   Once a hole is blown (or cut) into CallMeCrazy 07/31/14 10:13:42 AM
#64185   Existing antibacterials do two things to fight bacterial DaubersUP 07/31/14 10:07:29 AM
#64184   And we will find that out probably in DaubersUP 07/31/14 09:46:01 AM
#64183   So in other words,... once a big hole cabel 07/31/14 09:45:59 AM
#64182   I think another good analogy regarding how B CallMeCrazy 07/31/14 09:42:02 AM
#64181   I was thinking of an analogy to describe cabel 07/31/14 08:45:52 AM
#64180   Excellent... I suppose it won't slow the relentless macnqueso 07/31/14 08:41:21 AM
#64179   remember the timeless saying.... "Doctor's orders" Matagordaville 07/31/14 08:36:14 AM
#64178   Standard practice for Data Release In Clinical Trials: CallMeCrazy 07/31/14 07:58:51 AM
#64177   We'll see which of us is right when georgejjl 07/31/14 07:30:55 AM
#64176   We're on such a roll here BigK. May BooDog 07/31/14 04:26:27 AM
#64175   That conversion in the link is used primarily BigKahuna 07/31/14 02:11:15 AM
#64174   Apparition - We understand your views on who RJFL 07/31/14 01:47:17 AM
#64173   DF isn't running squat. Company sponsored trial. Apparition 07/31/14 01:12:53 AM
#64172   The latest cohort is being treated with a georgejjl 07/31/14 01:03:00 AM
#64171   Make no mistake, I believe there's good things Apparition 07/31/14 01:00:52 AM
#64170   The dosage in humans is currently 215 mg/m2, BigKahuna 07/31/14 12:50:33 AM
#64169   Quality never goes out of style, and the etradeedge 07/31/14 12:00:40 AM
#64168   Do not expect miracles from Kevetrin georgejjl 07/30/14 11:38:05 PM
#64167   Autism http://cellceutix.com/autism/#sthash.SLjRKqIR.dpbs Good luck and [b georgejjl 07/30/14 11:33:16 PM
#64166   nice :-) grizzlyman 07/30/14 11:15:17 PM
#64165   DF runs the show. How hard is DaubersUP 07/30/14 10:03:23 PM
#64164   Is should be are. Go CTIX! TheDane 07/30/14 09:45:10 PM
#64163   I missed this Ellaruth article from last week: John B 07/30/14 09:16:54 PM
#64162   Agreed. That information would be interesting. Like I've BioHedge 07/30/14 08:36:37 PM
#64161   I saw the article as well, and would noretreat 07/30/14 08:09:19 PM
#64160   Thank you for pointing that out to me. frrol 07/30/14 07:27:40 PM
#64159   frrol, congratulations! ellaruth used your reply to CallMeCrazy 07/30/14 05:34:39 PM
#64154   Obviously, I'm not understanding you. MrW 07/30/14 04:07:12 PM
#64153   Ok. And? What's your point? Apparition 07/30/14 03:54:16 PM
#64152   your welcome, I had to google her name grizzlyman 07/30/14 03:42:33 PM
#64151   Ellaruth posted my entire article, post #64056 on CallMeCrazy 07/30/14 03:37:32 PM
#64150   Post 64132 "All I'm asking is for is what MrW 07/30/14 03:35:49 PM
#64148   Way to change the subject. Never said it. Apparition 07/30/14 03:32:55 PM
#64147   You said you wanted what was "promised." Guess MrW 07/30/14 03:23:08 PM
#64145   Menon simply changed his mind due to the Apparition 07/30/14 03:20:13 PM
#64144   That's pretty evident. Good post. Apparition 07/30/14 03:16:30 PM
#64143   Better yet, you tell us why they haven't MrW 07/30/14 03:15:16 PM
#64142   I have nothing nice to say at this Apparition 07/30/14 03:15:09 PM
#64141   their is 2 new ellaruth articles, one of ctix 07/30/14 03:15:08 PM
#64140   The great thing about the USA is that BioHedge 07/30/14 03:14:51 PM
#64137   I agree. No matter how much we want JPsooner 07/30/14 03:11:21 PM
#64136   I don't mean to be rude, but I MrW 07/30/14 03:09:32 PM
#64134   Ok... And? What's your point? Apparition 07/30/14 03:01:35 PM